These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9097801)

  • 1. Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control study.
    Seregard S; af Trampe E; Månsson-Brahme E; Kock E; Bergenmar M; Ringborg U
    Ophthalmology; 1995 Oct; 102(10):1524-9. PubMed ID: 9097801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens.
    Novais GA; Fernandes BF; Belfort RN; Castiglione E; Cheema DP; Burnier MN
    Int J Surg Pathol; 2010 Feb; 18(1):60-3. PubMed ID: 18611943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it necessary to perform eye examination for patients with cutaneous atypical nevi?
    Karaarslan I; Yagcı A; Acar A; Sahin A; Ozkapu T; Palamar M; Ozdemir F
    Dermatol Ther; 2020 Nov; 33(6):e14503. PubMed ID: 33142003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between intraocular melanoma and cutaneous dysplastic nevi.
    Taylor MR; Guerry D; Bondi EE; Shields JA; Augsburger JJ; Lusk EJ; Elder DE; Clark WH; Van Horn M
    Am J Ophthalmol; 1984 Oct; 98(4):478-82. PubMed ID: 6486223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three cases of primary acquired melanosis of the conjunctiva as a manifestation of the atypical mole syndrome.
    Bataille V; Boyle J; Hungerford JL; Newton JA
    Br J Dermatol; 1993 Jan; 128(1):86-90. PubMed ID: 8427827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo confocal microscopy of pigmented conjunctival tumors.
    Messmer EM; Mackert MJ; Zapp DM; Kampik A
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1437-45. PubMed ID: 16598465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
    Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
    Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular melanomas and melanocytic lesions of the eye.
    Grin JM; Grant-Kels JM; Grin CM; Berke A; Kels BD
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):716-30. PubMed ID: 9591817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival and uveal melanoma in the dysplastic nevus syndrome.
    McCarthy JM; Rootman J; Horsman D; White VA
    Surv Ophthalmol; 1993; 37(5):377-86. PubMed ID: 8484171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are atypical nevi a risk factor for uveal melanoma? A case-control study.
    van Hees CL; de Boer A; Jager MJ; Bleeker JC; Kakebeeke HM; Crijns MB; Vandenbroucke JP; Bergman W
    J Invest Dermatol; 1994 Aug; 103(2):202-5. PubMed ID: 8040610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6180-2. PubMed ID: 20631239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular findings in patients with dysplastic nevus syndrome. An update.
    Rodriguez-Sains RS
    Dermatol Clin; 1991 Oct; 9(4):723-8. PubMed ID: 1934647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular pigmented findings in patients with dysplastic naevus syndrome.
    Toth-Molnar E; Olah J; Dobozy A; Hammer H
    Melanoma Res; 2004 Feb; 14(1):43-7. PubMed ID: 15091193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of melanocytic conjunctival tumors.
    Halas JM; Svetlosakova Z; Babal P
    Bratisl Lek Listy; 2013; 114(8):446-50. PubMed ID: 23944618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential diagnosis and management of melanocytic lesions of the ocular surface].
    Tóth G; Szalai E; Csákány B; Hécz R; Sándor GL; Lukáts O; Nagy ZZ; Szentmáry N
    Orv Hetil; 2020 Apr; 161(15):563-574. PubMed ID: 32320191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunctival pigmented lesion: Clinicopathological analysis of 85 cases in Korean population.
    Lee YJ; Lee C; Kim MK; Khwarg SI; Oh JY
    Sci Rep; 2019 Dec; 9(1):18204. PubMed ID: 31796811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current appraisal of conjunctival melanocytic tumors: classification and treatment.
    Harooni H; Schoenfield LR; Singh AD
    Future Oncol; 2011 Mar; 7(3):435-46. PubMed ID: 21417906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding of conjunctival melanocytic pigmented lesions within pterygium.
    Perra MT; Colombari R; Maxia C; Zucca I; Piras F; Corbu A; Bravo S; Scarpa A; Sirigu P
    Histopathology; 2006 Mar; 48(4):387-93. PubMed ID: 16487360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.